
|Articles|July 1, 2003
Itch Treatments
San Francisco - A better understanding of the pathophysiologic mediators of itch has led to some novel and promising approaches to its successful treatment, Gil Yosipovitch, M.D., said at the annual meeting of the American Academy of Dermatology. Several exciting systemic therapies approved for the treatment of various neurologically mediated disorders now show potential in the treatment of itch.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















